Compass Therapeutics, Inc. (CMPX) NASDAQ
2.08
-0.14(-6.31%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.08
-0.14(-6.31%)
Currency In USD
| Market Cap | 846.82M |
| Enterprise Value | 826.01M |
| P/E Ratio | -5.69 |
| PEG Ratio | 0.63 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.08 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.34 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.33 |
| Return On Equity | -0.4 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -1.47M |
| EBITDA | -71.37M |
| Net Income | -66.49M |
| Diluted EPS | -0.42 |
| Total Cash | 194.69M |
| Total Cash/Share | 1.04 |
| Total Debt | 9.79M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 19.04 |
| Book Value Per Share | 1 |
| 52-Week Change | -3.26 |
| 52-Week High | 6.88 |
| 52-Week Low | 1.61 |
| Moving Average 50 Days | 3.68 |
| Moving Average 200 Days | 4.5 |
| Average Volume | 7.44M |
| Shares Outstanding | 138.29M |
| % Held by Institutions | 109.86 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |